{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:27:55Z","timestamp":1781764075214,"version":"3.54.5"},"reference-count":25,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hematology Reports"],"abstract":"<jats:p>We report a patient with hemophilia A who underwent partial splenic embolization (PSE) for severe thrombocytopenia secondary to portal hypertension-induced splenomegaly, resulting in a stable long-term quality of life. The patient was diagnosed with hemophilia A and unfortunately contracted human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) from blood products. He subsequently developed progressive splenomegaly due to portal hypertension from chronic HCV, resulting in severe thrombocytopenia. PSE was performed because he had occasional subcutaneous bleeding and needed to start interferon (IFN) and ribavirin (RBV) treatment for curing his HCV infection at that time. His platelet counts increased, and no serious adverse events were observed. Currently, he continues to receive outpatient treatment, regular factor VIII (FVIII) replacement therapy for hemophilia A, and antiretroviral therapy for HIV infection. Vascular embolization has been reported to be an effective and minimally invasive treatment for bleeding in hemophilia patients. PSE also provided him with a stable quality of life without the side effects of serious infections and thrombocytopenia relapses. We conclude that PSE is a promising therapeutic option for patients with hemophilia A.<\/jats:p>","DOI":"10.3390\/hematolrep16020019","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T13:44:00Z","timestamp":1711460640000},"page":"185-192","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Partial Splenic Embolization in a Patient with Hemophilia A and Severe Thrombocytopenia: A Case Report"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7589-9514","authenticated-orcid":false,"given":"Tomofumi","family":"Nakamura","sequence":"first","affiliation":[{"name":"Department of Hematology, Rheumatology, and Infectious Diseases, Graduate School of Medical Sciences, Faculty of Life Sciences, Kumamoto University, Kumamoto 860-8556, Japan"},{"name":"Department of Laboratory Medicine, Kumamoto University Hospital, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Uchiba","sequence":"additional","affiliation":[{"name":"Department of Blood Transfusion and Cell Therapy, Kumamoto University Hospital, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotomo","family":"Nakata","sequence":"additional","affiliation":[{"name":"Department of Hematology, Rheumatology, and Infectious Diseases, Kumamoto University Hospital, Kumamoto 860-8556, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Mizumoto","sequence":"additional","affiliation":[{"name":"Department of Surgery, National Hospital Organization Kumamoto Medical Center, Kumamoto 860-0008, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9046-0454","authenticated-orcid":false,"given":"Toru","family":"Beppu","sequence":"additional","affiliation":[{"name":"Department of Surgery, Yamaga City Medical Center, Kumamoto 861-0501, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuzo","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Collaborative Research Program for Anti-Viral Agents and Hematological Diseases, Division of Clinical Retrovirology, Joint Research Center for Human Retrovirus Infection, Kumamoto University, Kumamoto 862-0973, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-021-00278-x","article-title":"Haemophilia","volume":"7","author":"Berntorp","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000503889","article-title":"Hemophilia A in females: Considerations for clinical management","volume":"143","author":"Bryant","year":"2020","journal-title":"Acta Haematol."},{"key":"ref_3","first-page":"221","article-title":"Recent advances in the treatment of hemophilia: A review","volume":"15","author":"Marchesini","year":"2021","journal-title":"Biologics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3324\/haematol.2019.232132","article-title":"Hemophilia therapy: The future has begun","volume":"105","author":"Mannucci","year":"2020","journal-title":"Haematologica"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.3748\/wjg.v20.i10.2595","article-title":"Management of thrombocytopenia due to liver cirrhosis: A review","volume":"20","author":"Hayashi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.jceh.2018.06.520","article-title":"Partial splenic artery embolization therapy in hemophilia A with decompensated cld causing hypersplenism: Caution to hepatologists-a case report","volume":"8","author":"Ahire","year":"2018","journal-title":"J. Clin. Exp. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2516.2004.00944.x","article-title":"The rare coagulation disorders-review with guidelines for management from the United Kingdom Haemophilia Centre Doctors\u2019 Organisation","volume":"10","author":"Perry","year":"2004","journal-title":"Haemophilia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Krag","year":"2021","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/00004424-197307000-00054","article-title":"Embolic therapy for hypersplenism","volume":"8","author":"Maddison","year":"1973","journal-title":"Investig. Radiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2214\/ajr.132.5.777","article-title":"Partial splenic embolization in the treatment of hypersplenism","volume":"132","author":"Spigos","year":"1979","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2169\/internalmedicine.48.1649","article-title":"Partial splenic embolization reverses insulin resistance in patients with liver cirrhosis","volume":"48","author":"Shimizu","year":"2009","journal-title":"Intern. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2169\/internalmedicine.53.1842","article-title":"Long-term evaluation of partial splenic embolization followed by interferon therapy in patients with hepatitis C virus (HCV) cirrhosis and thrombocytopenia","volume":"53","author":"Shimizu","year":"2014","journal-title":"Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00535-009-0185-9","article-title":"Therapeutic factors considered according to the preoperative splenic volume for a prolonged increase in platelet count after partial splenic embolization for liver cirrhosis","volume":"45","author":"Hayashi","year":"2010","journal-title":"J. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/hae.14835","article-title":"Preoperative synovial hyperaemia in haemophilia patients undergoing total knee replacement and the effects of genicular artery embolization: A retrospective cohort study","volume":"29","author":"Foppen","year":"2023","journal-title":"Haemophilia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1007\/s00270-019-02367-7","article-title":"Endovascular Management of Hemarthrosis in Patients with Bleeding Diatheses: Systematic Review","volume":"43","author":"Shanmugasundaram","year":"2020","journal-title":"Cardiovasc. Intervent. Radiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1111\/hae.12629","article-title":"Selective angiographic embolization for recurrent elbow and knee haemarthroses in haemophilia: A retrospective case series","volume":"21","author":"Obaji","year":"2015","journal-title":"Haemophilia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2516.2008.01842.x","article-title":"Successful angiographic embolization of recurrent elbow and knee joint bleeds in seven patients with severe haemophilia","volume":"15","author":"Klamroth","year":"2009","journal-title":"Haemophilia"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1182\/blood-2004-06-2063","article-title":"Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization","volume":"105","author":"Zijl","year":"2005","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"40094","DOI":"10.57187\/smw.2023.40094","article-title":"Management of abdominal pseudotumours in haemophilia: A systematic review","volume":"153","author":"Hegemann","year":"2023","journal-title":"Swiss Med. Wkly."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s42155-022-00299-x","article-title":"Prostatic artery embolization in men with severe hemophilia a: A case report of two patients","volume":"5","author":"Svarc","year":"2022","journal-title":"CVIR Endovasc."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s12185-017-2312-3","article-title":"Availability of angiography and therapeutic embolization for the treatment of acute bleeding in patients with hemophilia","volume":"106","author":"Kim","year":"2017","journal-title":"Int. J. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"20151064","DOI":"10.1259\/bjr.20151064","article-title":"Role of endovascular embolization in treatment of acute bleeding complications in haemophilia patients","volume":"89","author":"Garge","year":"2016","journal-title":"Br. J. Radiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7861\/clinmedicine.2-5-440","article-title":"Uptake of guideline for the prevention and treatment of infection in patients with an absent or dysfunctional spleen","volume":"2","author":"Davies","year":"2002","journal-title":"Clin. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/hepr.12184","article-title":"Nationwide survey in Japan regarding splenectomy\/partial splenic embolization or interferon treatment targeting hepatitis C virus-related chronic liver disease in patients with low platelet count","volume":"44","author":"Ikeda","year":"2014","journal-title":"Hepatol. Res."},{"key":"ref_25","first-page":"499","article-title":"Detection, Education and Management of the Asplenic or Hyposplenic Patient","volume":"63","author":"Brigden","year":"2001","journal-title":"Am. Fam. Physician"}],"container-title":["Hematology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2038-8330\/16\/2\/19\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:18:47Z","timestamp":1760105927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2038-8330\/16\/2\/19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":25,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["hematolrep16020019"],"URL":"https:\/\/doi.org\/10.3390\/hematolrep16020019","relation":{},"ISSN":["2038-8330"],"issn-type":[{"value":"2038-8330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]}}}